About EKF
EKF is a company based in Penarth (United Kingdom) founded in 1990 by Berthold Walter.. EKF has raised $178.63 thousand across 2 funding rounds from investors including Renalytix Tech and Seneca Growth Capital. The company has 303 employees as of December 31, 2024. EKF has completed 6 acquisitions, including ADL Health, Advanced Diagnostic Lab and DiaSpect. EKF offers products and services including DiaSpect Tm, Biosen C-Line, Quo-Test, Lactate Scout Sport, and Beta-Hydroxybutyrate LiquiColor. EKF operates in a competitive market with competitors including LumiraDx, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
- Headquarter Penarth, United Kingdom
- Employees 303 as on 31 Dec, 2024
- Founders Berthold Walter
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ekf Diagnostics Holdings Plc
-
Annual Revenue
$62.88 M (USD)-4.59as on Dec 31, 2024
-
Net Profit
$7.82 M (USD)165.39as on Dec 31, 2024
-
EBITDA
$14.01 M (USD)9.41as on Dec 31, 2024
-
Total Equity Funding
$178.63 K (USD)
in 2 rounds
-
Latest Funding Round
$28.67 M (USD), Post-IPO
Nov 01, 2018
-
Investors
Renalytix Tech
& 1 more
-
Employee Count
303
as on Dec 31, 2024
-
Investments & Acquisitions
ADL Health
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of EKF
EKF is a publicly listed company on the LSE with ticker symbol EKF in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of EKF
EKF offers a comprehensive portfolio of products and services, including DiaSpect Tm, Biosen C-Line, Quo-Test, Lactate Scout Sport, and Beta-Hydroxybutyrate LiquiColor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hemoglobin analyzer for diagnostics and blood donation testing.
Analyzer for glucose and HbA1C measurement in diabetes monitoring.
Rapid HbA1C tester for precise diabetes diagnostics.
Lactate and glucose device for sports performance optimization.
Reagent for detecting ketones in diabetic ketoacidosis.
Unlock access to complete
Funding Insights of EKF
EKF has successfully raised a total of $178.63K across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $28.67 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $28.7M
-
First Round
First Round
(01 Jun 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Post-IPO - EKF | Valuation |
investors |
|
| Jun, 2010 | Amount | Private Equity Round - EKF | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EKF
EKF has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Renalytix Tech and Seneca Growth Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of AI-based kidney disease diagnosis tool for healthcare professionals
|
Founded Year | Domain | Location | |
|
Assets are managed for growth-oriented investments in the UK.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EKF
EKF has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ADL Health, Advanced Diagnostic Lab and DiaSpect. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
COVID-19 RT-PCR testing services are provided in San Antonio.
|
2019 | ||||
|
Laboratory services including biochemistry, hematology, and microbiology are offered.
|
2017 | ||||
|
Molecular diagnostics are provided for drug discovery and clinical use.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - EKF
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ekf Comparisons
Competitors of EKF
EKF operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LumiraDx, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud based diagnostics platform for point of care diagnosing
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
|
|
| domain | founded_year | HQ Location |
Medical diagnostics solutions are researched by the laboratory.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ekf
Frequently Asked Questions about EKF
When was EKF founded?
EKF was founded in 1990 and raised its 1st funding round 20 years after it was founded.
Where is EKF located?
EKF is headquartered in Penarth, United Kingdom. It is registered at Penarth, Wales, United Kingdom.
Who is the current CEO of EKF?
Julian Baines is the current CEO of EKF.
Is EKF a funded company?
EKF is a funded company, having raised a total of $178.63K across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $178.63K, raised on Jun 01, 2010.
How many employees does EKF have?
As of Dec 31, 2024, the latest employee count at EKF is 303.
What is the annual revenue of EKF?
Annual revenue of EKF is $62.88M as on Dec 31, 2024.
What does EKF do?
EKF Diagnostics was founded in 1990 and is headquartered in Penarth, United Kingdom. Blood analyzers for point-of-care and laboratory use are produced, with platforms focused on hematology, diabetes management, reproductive health, maternal care, and sports medicine. Laboratory equipment including centrifuges, clinical chemistry systems, immunoassays, infectious disease tests, and urine analyzers is also manufactured. Operations center on diagnostic tools for healthcare settings worldwide.
What products or services does EKF offer?
EKF offers DiaSpect Tm, Biosen C-Line, Quo-Test, Lactate Scout Sport, and Beta-Hydroxybutyrate LiquiColor.
Is EKF publicly traded?
Yes, EKF is publicly traded on LSE under the ticker symbol EKF.
How many acquisitions has EKF made?
EKF has made 6 acquisitions, including ADL Health, Advanced Diagnostic Lab, and DiaSpect.
Who are EKF's investors?
EKF has 2 investors. Key investors include Renalytix Tech, and Seneca Growth Capital.
What is EKF's ticker symbol?
The ticker symbol of EKF is EKF on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.